Pfizer Said It Expected 2021 Sales of the COVID-19 Vaccine It Developed with German ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Pfizer said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech to reach $36 billion and forecast another $29 billion from the shot in 2022, topping analyst estimates for both years ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)